S Kapiotis Selected Research

S Kapiotis Research Topics

Disease

6	Atherosclerosis 06/2014 - 01/2000
5	Inflammation (Inflammations) 08/2008 - 05/2000
3	Thrombosis (Thrombus) 11/2014 - 03/2000
2	Atrial Fibrillation 11/2014 - 06/2011
2	Acute Coronary Syndrome 11/2014 - 12/2001
2	Type 2 Diabetes Mellitus (MODY) 11/2008 - 01/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2020
1	Hyperuricemia 05/2020
1	Chronic Renal Insufficiency 06/2014
1	Stroke (Strokes) 06/2011
1	Venous Thromboembolism 06/2011
1	Endotoxemia 08/2008
1	Renal Insufficiency (Renal Failure) 01/2007
1	Albuminuria 01/2007
1	Necrosis 12/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2001
1	Neoplasm Metastasis (Metastasis) 03/2001
1	Diabetes Complications 01/2001
1	Vascular Diseases (Vascular Disease) 01/2001
1	Hemorrhage 08/2000
1	Postoperative Hemorrhage 08/2000
1	Leukemia 04/2000
1	Critical Illness (Critically Ill) 03/2000
1	Rheumatoid Arthritis 01/2000
1	Osteoarthritis 01/2000

Drug/Important Bio-Agent (IBA)

4	oxidized low density lipoproteinIBA 06/2014 - 03/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006 - 02/2001
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2003 - 03/2001
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2001 - 03/2000
2	Glucose (Dextrose)FDA LinkGeneric 01/2001 - 03/2000
2	ProstaglandinsIBA 08/2000 - 05/2000
1	Uric Acid (Urate)IBA 05/2020
1	Uremic ToxinsIBA 06/2014
1	Factor Xa (Coagulation Factor Xa)IBA 06/2011
1	edoxabanIBA 06/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2008
1	Angiotensin Receptor AntagonistsIBA 11/2008
1	Pioglitazone (Actos)FDA Link 08/2008
1	EndotoxinsIBA 08/2008
1	CytokinesIBA 08/2008
1	dimethylarginineIBA 01/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2007
1	Interleukin-10 (Interleukin 10)IBA 12/2006
1	Interleukin-6 (Interleukin 6)IBA 12/2006
1	InterleukinsIBA 12/2006
1	Insulin (Novolin)FDA Link 08/2006
1	Nicotinamide PhosphoribosyltransferaseIBA 08/2006
1	AdipokinesIBA 08/2006
1	Escherichia coli endotoxinIBA 09/2003
1	LipopolysaccharidesIBA 09/2003
1	NucleotidesIBA 12/2001
1	5' Untranslated Regions (5' UTR)IBA 12/2001
1	Factor XII (Hageman Factor)IBA 12/2001
1	AntibodiesIBA 04/2001
1	Erythropoietin FDA Link 04/2001
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2001
1	NF-KappaB Inhibitor alphaIBA 02/2001
1	NF-kappa B (NF-kB)IBA 02/2001
1	Blood Coagulation Factors (Coagulation Factor)IBA 02/2001
1	GenisteinIBA 01/2001
1	Advanced Glycation End ProductsIBA 01/2001
1	Alprostadil (Muse)FDA LinkGeneric 08/2000
1	HLA-DR Antigens (HLA-DR)IBA 04/2000
1	AntigensIBA 04/2000
1	Heparin (Liquaemin)FDA LinkGeneric 03/2000
1	Stem Cell FactorIBA 01/2000
1	von Willebrand FactorIBA 01/2000

Therapy/Procedure

2	Therapeutics 11/2014 - 09/2003
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2000
1	Catheters 03/2000